UB Paderborn / Katalog / Suche / in CDI

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

European journal of cancer (1990), 2013-11, Vol.49 (16), p.3431-3441

2013

Volltextzugriff (PDF)

Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer

Clinical cancer research, 2011-05, Vol.17 (10), p.3368-3377

2011

Volltextzugriff (PDF)

Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients

Cancers, 2021-05, Vol.13 (10), p.2360

2021

Volltextzugriff (PDF)

Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study

PloS one, 2017-08, Vol.12 (8), p.e0182223-e0182223

2017

Volltextzugriff (PDF)

Increased circulating hepatocyte growth factor (HGF): A marker of epithelial ovarian cancer and an indicator of poor prognosis

Gynecologic oncology, 2011-05, Vol.121 (2), p.402-406

2011

Volltextzugriff (PDF)

Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm

Gynecologic oncology, 2016-12, Vol.143 (3), p.479-483

2016

Volltextzugriff (PDF)

Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial

European journal of cancer (1990), 2020-09, Vol.137, p.69-80

2020

Volltextzugriff (PDF)

Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy

American journal of obstetrics and gynecology, 1993-08, Vol.169 (2), p.397-404

1993

Volltextzugriff (PDF)

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

European journal of cancer (1990), 2012-09, Vol.48 (13), p.1988-1996

2012

Volltextzugriff (PDF)

The effect of centralization of primary surgery on survival in ovarian cancer patients

Obstetrics and gynecology (New York. 1953), 2003-09, Vol.102 (3), p.499-505

2003

Volltextzugriff (PDF)

Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients

British journal of cancer, 2017-09, Vol.117 (6), p.840-847

2017

Volltextzugriff (PDF)

DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer

British journal of cancer, 2015-05, Vol.112 (10), p.1656-1664

2015

Volltextzugriff (PDF)

Ten Years’ Experience With Centralized Surgery of Ovarian Cancer in One Health Region in Norway

International journal of gynecological cancer, 2012-02, Vol.22 (2), p.226-231

2012

Volltextzugriff (PDF)

Community-Based Health Education has Positive Influence on the Attitude to Cervical Cancer Screening among Women in Rural Nepal

Journal of cancer education, 2016-09, Vol.31 (3), p.547-553

2016

Volltextzugriff (PDF)

Survival and prognostic factors in patients with ovarian cancer

Obstetrics and gynecology (New York. 1953), 2003-05, Vol.101 (5), p.885-891

2003

Volltextzugriff (PDF)

Prevalence of human papillomavirus infection among women in rural Nepal

Acta obstetricia et gynecologica Scandinavica, 2017-01, Vol.96 (1), p.29-38

2017

Volltextzugriff (PDF)

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas

International journal of clinical and experimental pathology, 2011-06, Vol.4 (5), p.444-453

2011

Volltextzugriff (PDF)

Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer

Cancer epidemiology, biomarkers & prevention, 2017-01, Vol.26 (1), p.61-67

2017

Volltextzugriff (PDF)

Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)

Cancers, 2020-04, Vol.12 (5), p.1115

2020

Volltextzugriff (PDF)

THE RISK-OF-MALIGNANCY INDEX TO EVALUATE POTENTIAL OVARIAN CANCERS IN LOCAL HOSPITALS

Obstetrics and gynecology (New York. 1953), 1999-03, Vol.93 (3), p.448-452

1999

Volltextzugriff (PDF)

Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway

International journal of cancer, 2002-04, Vol.98 (6), p.907-911

2002

Volltextzugriff (PDF)

Circulating interleukin-8 and plasminogen activator inhibitor-1 are increased in women with ovarian carcinoma

Results in immunology, 2012, Vol.2, p.190-195

2012

Volltextzugriff (PDF)

The Effect of Centralization of Primary Surgery on Survival in Ovarian Cancer Patients

Obstetrics and gynecology (New York. 1953), 2003-09, Vol.102 (3), p.499-505

2003

Volltextzugriff (PDF)

Survival and Prognostic Factors in Patients With Ovarian Cancer

Obstetrics and gynecology (New York. 1953), 2003-05, Vol.101 (5, Part 1), p.885-891

2003

Volltextzugriff (PDF)

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass

International journal of cancer, 2000-11, Vol.89 (6), p.519-523

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer

Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients

Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study

Increased circulating hepatocyte growth factor (HGF): A marker of epithelial ovarian cancer and an indicator of poor prognosis

Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm

Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial

Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

The effect of centralization of primary surgery on survival in ovarian cancer patients

Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients

DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer

Ten Years’ Experience With Centralized Surgery of Ovarian Cancer in One Health Region in Norway

Community-Based Health Education has Positive Influence on the Attitude to Cervical Cancer Screening among Women in Rural Nepal

Survival and prognostic factors in patients with ovarian cancer

Prevalence of human papillomavirus infection among women in rural Nepal

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas

Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer

Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)

THE RISK-OF-MALIGNANCY INDEX TO EVALUATE POTENTIAL OVARIAN CANCERS IN LOCAL HOSPITALS

Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway

Circulating interleukin-8 and plasminogen activator inhibitor-1 are increased in women with ovarian carcinoma

The Effect of Centralization of Primary Surgery on Survival in Ovarian Cancer Patients

Survival and Prognostic Factors in Patients With Ovarian Cancer

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass

Suchergebnisse filtern